Using the S100B Protein for Emergency Headache Management Care (S100)
NCT03490500 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 63
Last updated 2022-10-13
Summary
The purpose of this study is to determine the negative predictive value of protein S100B that could exclude subarachnoid and intracranial haemorrhage for patient that present severe headache within the last 3 hours.
Conditions
- Headache, Migraine
- Hemorrhage
Sponsors & Collaborators
-
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
lead OTHER
Principal Investigators
-
Aurélien Renard, MD · Hôpital d'instruction des armées Sainte-Anne
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-10-24
- Primary Completion
- 2020-01-24
- Completion
- 2020-01-24
Countries
- France
Study Locations
More Related Trials
-
Study of Treatment Used for Migraine Headaches (MK-0974-076)
NCT01421277 ·Status: TERMINATED
-
Protocol to Ease Acute Cephalalgia in Emergency-department
NCT02236442 ·Status: COMPLETED ·Phase: NA
-
Prospective ED Headache Cohort Study
NCT00313703 ·Status: COMPLETED
-
A Study Evaluating Oral Atogepant for the Prevention of Migraine in Japanese Participants With Chronic or Episodic Migraine
NCT04437433 ·Status: COMPLETED ·Phase: PHASE3
-
Monoclonal Antibody Duration of REsponse in MIgraine After Treatment Interruption
NCT05232942 ·Status: RECRUITING
-
Investigate the Mechanisms, Predictors, and Prevention of Persistent Post-Traumatic Headache
NCT04369729 ·Status: COMPLETED
-
Ubrogepant treatmeNt in mIgraine Patients Utilizing mOnoclonal aNtibodies
NCT05503082 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Study in Participants With Acute Migraines Headaches
NCT00804973 ·Status: TERMINATED ·Phase: PHASE2
-
A Retrospective Study to Evaluate the Effectiveness and Benefit of onabotulinumtoxinA in Patients With Chronic Migraines
NCT01749410 ·Status: COMPLETED
-
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
NCT01516892 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Intravenous Erenumab in Patients With Status Migrainosus
NCT04920331 ·Status: WITHDRAWN ·Phase: PHASE1
-
Physiopathology, Diagnosis and Therapy of Primary Cephalalgia and Adaptive Disorders
NCT04696510 ·Status: COMPLETED
-
MMA Embolization for Refractory Chronic Migraine
NCT06735833 ·Status: RECRUITING ·Phase: NA
-
Treatments of Migraine with Triptans in Individuals with Elevated Cardiovascular Risk and in Pregnant Women
NCT05854992 ·Status: COMPLETED
-
Study of Oral Atogepant Tablets to Assess Change in Disease Activity in Adult Japanese Participants With Episodic Migraine
NCT05861427 ·Status: COMPLETED ·Phase: PHASE3
-
Standardized sTudy With Almotriptan in eaRly Treatment of Migraine
NCT00725140 ·Status: COMPLETED
-
Pilot Study for a Machine Learning Test for Migraine
NCT05517200 ·Status: UNKNOWN
-
A Retrospective Study to Evaluate the Effectiveness of onabotulinumtoxinA in Preventing Headaches in Patients With Chronic Migraines
NCT01749423 ·Status: WITHDRAWN
-
BIOmarkers of MIGraine: a Proof of Concept Study Based on the Stratification of Responders to CGRP Monoclonal Antibodies
NCT04503083 ·Status: UNKNOWN
-
Investigation of Vascular Inflammation in Migraine Using Molecular Nano-imaging and Black Blood Imaging MRI
NCT02549898 ·Status: COMPLETED ·Phase: NA
-
Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache
NCT00534560 ·Status: COMPLETED ·Phase: PHASE2
-
COACT Study: CGRPmAbs + OnabotulinumtoxinA Assessment of Chronic Migraine Treatments Study
NCT05724771 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Treatment of Chronic Post-Traumatic Headache With OnabotulinumtoxinA
NCT02160535 ·Status: TERMINATED ·Phase: PHASE3
-
A Phase 1 Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-313 in Healthy Participants
NCT05477095 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Tolerability of Erenumab in the Prophylactic Treatment of Persistent Post-Traumatic Headache
NCT03974360 ·Status: COMPLETED ·Phase: PHASE2